secwatch.observer — SEC 8-K summary
======================================

Issuer:     XBiotech Inc. (XBIT)
CIK:        0001626878
Form:       8-K
Filed at:   2025-12-09T23:59:59+00:00
Accession:  0001171843-25-007836
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

XBiotech CEO John Simard retires; CSO Sushma Shivaswamy named interim CEO
-------------------------------------------------------------------------

- John Simard retired as CEO/President effective Dec 8, 2025; continues as Chairman.
- Sushma Shivaswamy, 47, appointed interim CEO effective Dec 8, remains CSO.
- Shivaswamy's base salary increased to $750k while serving in dual roles.
- Simard to provide consulting guidance per existing employment agreement; severance to be paid.
- Board thanks Simard for 21 years; confident in Shivaswamy's leadership during interim period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325007836/0001171843-25-007836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626878/000117184325007836/f8k_120825.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer